Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†☆

M Dreyling, M Ghielmini, S Rule, G Salles… - Annals of …, 2021 - annalsofoncology.org
Follicular lymphoma international prognostic index 2: a new prognostic index for follicular
lymphoma developed by the international follicular lymphoma prognostic factor project. …

How I treat early-relapsing follicular lymphoma

C Casulo, PM Barr - Blood, The Journal of the American Society …, 2019 - ashpublications.org
… of follicular lymphoma. (A) Predominance of small centrocytes in follicular lymphoma (… (B)
BCL2 expression in follicular lymphoma (immunohistochemical stain for BCL2; original …

Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial

NH Fowler, M Dickinson, M Dreyling… - Nature medicine, 2022 - nature.com
relapsed/refractory (r/r) B-cell lymphoma. In a previous pilot study of tisagenlecleucel in r/r
follicular lymphoma … more treatment lines or who relapsed after autologous stem cell transplant …

Follicular lymphoma

A Carbone, S Roulland, A Gloghini, A Younes… - Nature reviews Disease …, 2019 - nature.com
lymphomas are named according to the location of the related cell type within the lymphoid
follicle 3 and include follicular lymphoma … analysis revealed that relapse events (relapse 2) or …

Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma

AS Freedman, D Neuberg, P Mauch… - Blood, The Journal …, 1999 - ashpublications.org
… (ABMT) in patients with relapsed indolent follicular lymphoma. Between March 1985 and May
1995, … and first recurrence of patients with advanced follicular lymphoma are 8 and 5 years, …

Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

M Dreyling, M Ghielmini, R Marcus… - Annals of …, 2014 - annalsofoncology.org
Follicular lymphomas (FLs) are the second most frequent subtype of nodal lymphoid malignancies
in Western Europe. The annual incidence of this disease has rapidly increased during …

Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial

F Morschhauser, H Tilly, A Chaidos, P McKay… - The Lancet …, 2020 - thelancet.com
Background Activating mutations of EZH2, an epigenetic regulator, are present in approximately
20% of patients with follicular lymphoma. We investigated the activity and safety of …

Sequencing of therapies in relapsed follicular lymphoma

LJ Nastoupil, CR Flowers… - Hematology 2014, the …, 2018 - ashpublications.org
… history of follicular lymphoma (FL), prognostic indices such as the Follicular Lymphoma
In the relapsed setting where therapeutic strategies are even more vast, there is a paucity of …

Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial

JR Westin, F Chu, M Zhang, LE Fayad, LW Kwak… - The lancet …, 2014 - thelancet.com
… We enrolled adult (≥18 years) patients with follicular lymphoma of grade 1–2, relapsing
after one to four previous therapies. Patients had to have rituximab-sensitive disease, defined …

[HTML][HTML] Mosunetuzumab shows promising efficacy in patients with multiply relapsed follicular lymphoma: updated clinical experience from a phase I dose-escalation …

SE Assouline, WS Kim, LH Sehn, SJ Schuster… - Blood, 2020 - Elsevier
… Introduction: Follicular lymphoma (FL) is considered an indolent yet incurable disease …
recurrent relapses: disease-free intervals shorten, and refractoriness increases with each relapse. …